Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Rosenfelder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Clinical Evidence|July 28, 2011
Brain metastasesNicola Rosenfelder, Vincent Khoo
Current Opinion in Oncology|August 23, 2019
Integrated treatment of brain metastasesNicola Rosenfelder, Michael Brada
BJR Case Reports|September 11, 2019
Bilateral adrenal-renal fusion: A radiological diagnosisRebecca Bamford, Josephine Bretherton, Nicola Rosenfelder, et al.
Practical Radiation Oncology|November 22, 2014
Intensity modulated radiation therapy allows prostate and dose-escalated pelvic radical radiation therapy after renal transplantationNicola Rosenfelder, Richard Corbett, Michelle Long, et al.
Neuro-Oncology Advances|May 21, 2024
A brain metastasis liquid biopsy: Where are we now?Stephen David Robinson, James de Boisanger, Frances M G Pearl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapyShreerang A Bhide, Sarah Gulliford, Jack Fowler, et al.
Cancers|March 28, 2024
Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)Shybi Mohamedkhan, Sumeet Hindocha, James de Boisanger, et al.
Acta Oncologica (Stockholm, Sweden)|October 7, 2017
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrenceOsman El Kabbaj, Philippe Robin, David Bourhis, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer MattersJames de Boisanger, Martin Brewer, Matthew W Fittall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2025
Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567)James de Boisanger, Amina Tran, Philip Benjamin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Clinical Evidence|July 28, 2011
Brain metastasesNicola Rosenfelder, Vincent Khoo
Current Opinion in Oncology|August 23, 2019
Integrated treatment of brain metastasesNicola Rosenfelder, Michael Brada
BJR Case Reports|September 11, 2019
Bilateral adrenal-renal fusion: A radiological diagnosisRebecca Bamford, Josephine Bretherton, Nicola Rosenfelder, et al.
Practical Radiation Oncology|November 22, 2014
Intensity modulated radiation therapy allows prostate and dose-escalated pelvic radical radiation therapy after renal transplantationNicola Rosenfelder, Richard Corbett, Michelle Long, et al.
Neuro-Oncology Advances|May 21, 2024
A brain metastasis liquid biopsy: Where are we now?Stephen David Robinson, James de Boisanger, Frances M G Pearl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapyShreerang A Bhide, Sarah Gulliford, Jack Fowler, et al.
Cancers|March 28, 2024
Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC)Shybi Mohamedkhan, Sumeet Hindocha, James de Boisanger, et al.
Acta Oncologica (Stockholm, Sweden)|October 7, 2017
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrenceOsman El Kabbaj, Philippe Robin, David Bourhis, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer MattersJames de Boisanger, Martin Brewer, Matthew W Fittall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2025
Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567)James de Boisanger, Amina Tran, Philip Benjamin, et al.
Pageof 1